• london biotech banner
  • Agora
  • Eioc Mededge
MedEdge MEA MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Reading: Urgent Health Alert: WHO Sounds Alarm on Dangerous Fake Painkiller
Share
Notification
  • london biotech banner
  • Agora
  • Eioc Mededge
MedEdge MEA
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Have an existing account? Sign In
MedEdge MEA > News > Urgent Health Alert: WHO Sounds Alarm on Dangerous Fake Painkiller
News

Urgent Health Alert: WHO Sounds Alarm on Dangerous Fake Painkiller

ME Desk
ME Desk
Published: August 9, 2024
Share
4 Min Read
Urgent Health Alert: WHO Sounds Alarm on Dangerous Fake Painkiller
SHARE

Geneva- August 2024- This WHO Medical Product Alert refers to one batch of falsified Oxymorphone Hydrochloride 40mg. The falsified product was detected in the unregulated supply chain in Finland and reported to WHO in July 2024 by the Finnish Medicines Agency (FIMEA). Oxymorphone Hydrochloride is a semi-synthetic opioid used to treat moderate to severe pain. However, laboratory analysis of samples of the falsified product found that the tablets contained metonitazene instead.

Contents
How to identify this falsified productRisksAdvices

Metonitazene is a potent psychoactive synthetic opioid drug, with not officially recognized or authorized medicinal or therapeutic use. It is under international control as a Schedule I narcotic drug following recommendations of the WHO Expert Committee on Drug Dependence in 2021. Small doses can result in serious adverse effects such as respiratory depression, severe sedation, addiction, and an overdose may be fatal.

How to identify this falsified product

This product is confirmed as falsified because it deliberately misrepresents its identity, composition, and source. The falsified product imitates Oxymorphone Hydrochloride marketed by AUROLIFE PHARMA LLC., who have confirmed that the product, subject of this Alert, is falsified and was not produced by their company. To identify this falsified product check for the following:

  • The falsified version label does not have a barcode on the bottle.
  • The falsified version is labelled 40mg. AUROLIFE PHARMA Oxymorphone Hydrochloride is only available as 5mg and 10mg doses.
  • The falsified versions of the tablets lack embossed letters/numbers.
  • The falsified product’s label is missing the National Drug Code of the United States of America. Please refer to the Annex of this Alert for full details of the falsified product.

Risks

This falsified product may have been intentionally designed to mimic products authorized by the U.S. Food and Drug Administration and marketed by AUROLIFE PHARMA LLC as Oxymorphone Hydrochloride. However, it contains undeclared metonitazene, which poses a significant risk to users due to the high likelihood of adverse events, even in small doses. Metonitazene produces effects similar to other opioids. Its high potency carries a high risk of overdose and death. Use of this falsified product may be life-threatening.

Advices

Healthcare professionals should report any incident of adverse effects, lack of expected effects or suspected falsification to the National Regulatory Authorities/National Pharmacovigilance Centre.

WHO advises increased surveillance and diligence within the supply chains of countries and regions likely to be affected by these falsified products. Increased surveillance of the informal/unregulated market is also advised. However, National regulatory authorities/health authorities/law enforcement are advised to immediately notify WHO if the falsified product is detected in their country.

Also Read: Don’t Get Duped! WHO Warns of Fake Weight Loss and Diabetes Treatments

If you are in possession any of these products, WHO recommends that you do not use them. If you, or someone you know, has, or may have used these products, or suffered an adverse event or unexpected side-effect after use, seek immediate medical advice from a healthcare professional or contact a poisons control centre.

Furthermore, All medical products must be obtained from authorized/licensed suppliers. If you have any information about the manufacture or supply of these falsified products, please contact WHO via rapidalert@who.int.

Also Read : WHO Report: Road traffic deaths rise in the African region

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article The Impact of Handling And Storage on Fertility Success The Impact of Handling And Storage on Fertility Success
Next Article Entos Pharmaceuticals Kicks Off COVID-19 Booster Trials Entos Pharmaceuticals Kicks Off COVID-19 Booster Trials

Recent Posts

  • ‘Simple, Relaxing Activities with Family and Friends Help Me Unwind’
  • Daman To Host Webinar on Thyroid Disorders and Obesity to Highlight the Importance of Early Detection
  • DoH and Boehringer Ingelheim Ink Strategic Partnership to Advance Life Science Innovation Across the Emirate
  • Holistic Health Middle East launches in Dubai this October in support of Dubai Fitness Challenge
  • Global Fertility Network Expands Regional Presence with Acquisition of HealthPlus Fertility in Jeddah
  • LifeSpin
  • Health ExpoIraq
  • Agora
  • Holistic Health Middle East
Two Point Five Logo white
  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: Urgent Health Alert: WHO Sounds Alarm on Dangerous Fake Painkiller
Share

Published by Two Point Five Media FZCO

  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: Urgent Health Alert: WHO Sounds Alarm on Dangerous Fake Painkiller
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?